A Multicentre Observational Study to Evaluate the Real-Life Effectiveness of Benepali® Following Transition From Enbrel® in Patients With Rheumatoid Arthritis (RA) and Axial Spondyloarthritis (axSpA) - The BENEFIT Study
Phase of Trial: Phase IV
Latest Information Update: 24 Oct 2018
At a glance
- Drugs Etanercept (Primary)
- Indications Ankylosing spondylitis; Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms The BENEFIT Study
- Sponsors Biogen
- 24 Oct 2018 Interim results (n=255) presented at the 82nd American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting
- 13 Sep 2018 Planned End Date changed from 1 Oct 2018 to 31 Jan 2019.
- 13 Sep 2018 Planned primary completion date changed from 31 Aug 2018 to 30 Nov 2018.